These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2424142)

  • 1. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine.
    Huang H; Yang Z; Xu Q; Sheng Z; Xie Y; Yan W; You Y; Sun L; Zheng Z
    Viral Immunol; 1999; 12(1):1-8. PubMed ID: 10333237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virion proteins and the perspectives of gene manipulations in vaccine preparation.
    Tickhonenko TI
    Acta Virol; 1985 May; 29(3):254-65. PubMed ID: 2413750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in viral vaccine development.
    Brown F
    Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of biotechnology to the control of foot-and-mouth disease virus.
    Kitching RP
    Br Vet J; 1992; 148(5):375-88. PubMed ID: 1330200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
    Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
    Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22].
    Onishchenko AM; Petrov NA; Blinov VM; Vasilenko SK; Sandakhchiev LS
    Bioorg Khim; 1986 Mar; 12(3):416-9. PubMed ID: 2421736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.